| Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767) |
|---|
| 05/28/2009 | US20090137512 nucleotide sequence complementary to a target RNA sequence and a second sequence chemically modified so it can no longer act as a guide sequence for mediating RNA interference, having complementarity to said first sequence; cancer, proliferative diseases |
| 05/28/2009 | US20090137511 RNA INTERFERENCE MEDIATED INHIBITION OF PLACENTAL GROWTH FACTOR GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA) |
| 05/28/2009 | US20090137509 RNA INTERFERENCE MEDIATED INHIBITION OF PROLIFERATION CELL NUCLEAR ANTIGEN (PCNA) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA) |
| 05/28/2009 | US20090137508 Treatment of any disease that responds to modulation of gene expression, for example cancer, proliferative, inflammatory, metabolic, autoimmune, neurologic, ocular diseases; in vivo stability and bioavailability |
| 05/28/2009 | US20090136473 Biaryl pde4 inhibitors for treating pulmonary and cardiovascular disorders |
| 05/28/2009 | US20090136429 Combination of Anticholinergics and Inhibitors of Phosphodiesterase Type 4 For The Treatment of Respiratory Disease |
| 05/28/2009 | US20090136427 LIGHT Inhibitors For Asthma, Lung and Airway Inflammation, Respiratory, Interstitial, Pulmonary and Fibrotic Disease Treatment |
| 05/28/2009 | CA2706536A1 Amorphous body composed of heterocyclic compound, solid dispersion and pharmaceutical preparation each comprising the same, and process for production of the same |
| 05/28/2009 | CA2706391A1 Spiropiperidines for use as tryptase inhibitors |
| 05/28/2009 | CA2704214A1 Pyrimidine derivatives for the treatment of asthma, copd, allergic rhinitis, allergic conjunctivitis, atopic dermatitis, cancer, hepatitis b, hepatitis c, hiv, hpv, bacterial infections and dermatosis |
| 05/27/2009 | EP2062879A1 Heterocyclic inhibitors of p38 |
| 05/27/2009 | EP2062595A1 Inhibition of inflammation using alpha 7 receptor-binding cholinergic agonists |
| 05/27/2009 | EP2062583A2 Therapeutic applications of pro-apoptotic benzodiazepines |
| 05/27/2009 | EP2061794A2 2-phenoxy pyrimidinone analogues |
| 05/27/2009 | EP2061793A2 Kw-3902 conjugates that do not cross the blood-brain barrier |
| 05/27/2009 | EP2061749A1 Positively charged water-soluble prodrugs of acetaminophen and related compounds with very fast skin penetration rate |
| 05/27/2009 | EP2061501A2 Method of treating respiratory disorders |
| 05/27/2009 | EP2061496A2 Methods of using il-31 to treat airway hyper-responsiveness and asthma |
| 05/27/2009 | EP2061470A2 Haloalkyl-substituted pyrimidinone derivatives |
| 05/27/2009 | EP2061446A2 Use of cdk inhibitors for the treatment of granulocyte mediated disorders |
| 05/27/2009 | EP2061315A2 Tonsillitis treatment |
| 05/27/2009 | EP1730141B1 Compounds for the treatment of diseases |
| 05/27/2009 | EP1519915B1 Tricyclic steroid hormone nuclear receptor modulators |
| 05/27/2009 | EP1487797B1 Hetero-bridge substituted 8-arylquinoline pde4 inhibitors |
| 05/27/2009 | EP1366075B1 New interferon beta-like molecules |
| 05/27/2009 | EP1292678B1 G-protein coupled receptors |
| 05/27/2009 | EP1037651B1 Small peptides and methods for treatment of asthma and inflammation |
| 05/27/2009 | CN101443349A Compounds and compositions as channel activating protease inhibitors |
| 05/27/2009 | CN101443348A Compounds and compositions as channel activating protease inhibitors |
| 05/27/2009 | CN101443344A Trehalose compound and pharmaceutical comprising the compound |
| 05/27/2009 | CN101443320A Bezothiazol derivatives as beta2 adrenoreceptor agonists |
| 05/27/2009 | CN101443292A New method for the manufacture of therapeutic compounds and compositions, compounds and compositions produced therewhith, and their use |
| 05/27/2009 | CN101443004A Formulations and methods for vascular permeability-related diseases or conditions |
| 05/27/2009 | CN101439177A Chinese medicinal composition for treating pharyngitis and production method |
| 05/27/2009 | CN101439175A Chinese medicine preparation for treating nephropathogenic infectious bronchitis in chicken |
| 05/27/2009 | CN101439166A Medicinal food for treating cough, asthma, pneumonia and tracheitis |
| 05/27/2009 | CN101439144A Chinese medicine composing prescription for treating children's bronchial asthma |
| 05/27/2009 | CN101439138A Medicament for treating non-gonococcal urethritis |
| 05/27/2009 | CN101439100A Technique for preparing globeflower capsule |
| 05/27/2009 | CN101439094A Chinese medicine decoction for treating common cold |
| 05/27/2009 | CN101439090A Formulation containing honeysuckle flower and scutellaria, and uses thereof |
| 05/27/2009 | CN101439083A Chinese medicine soft capsules for clearing wind heat and clearing nasal passage, as well as preparation method and quality control method |
| 05/27/2009 | CN101439062A Chinese medicine granule containing andrographolide and preparation method thereof |
| 05/27/2009 | CN101439060A Qualitative identification of Chinese medicine Bairui tablet and method for measuring kaempferol content therein |
| 05/27/2009 | CN101439059A Ginkgo leaf extract drop and preparation method thereof |
| 05/27/2009 | CN101439057A Chinese medicine granule containing gingko extract and preparation method thereof |
| 05/27/2009 | CN101439026A Controlled release preparation containing doxazosin or salt thereof and preparation method thereof |
| 05/27/2009 | CN100491374C 2-(3-aminoaryl)amino-4-aryl-thiazoles and their use as C-KIT inhibitors |
| 05/27/2009 | CN100491368C Derivatives of dioxane-2-alkyl carbamates, preparation thereof and application thereof in therapeutics |
| 05/27/2009 | CN100491355C Cyclic diamine compound having five-membered cyclic group |
| 05/27/2009 | CN100491353C Carboxylic acid derivative capable of inhibiting combination of integrin and its receptor |
| 05/27/2009 | CN100491352C Asymmetrical cyclic diamine compound |
| 05/27/2009 | CN100491342C Crystalline beta2 adrenergic receptor agonist |
| 05/27/2009 | CN100490888C Compositions for preventing or treating pollenosis, allergic nephritis, atopic dermatitits, asthma or urticaria |
| 05/27/2009 | CN100490877C Active extractive of Foliumnerviliae, preparation method and application |
| 05/27/2009 | CN100490876C Sarcadra injection, its making method and venous injection |
| 05/27/2009 | CN100490871C Combination of Chinese traditional medicine for curing chronic pharyngitis and preparation method |
| 05/27/2009 | CN100490866C Ready prepared Chinese medicine for treating deep source nasal congestion |
| 05/27/2009 | CN100490863C Preparing process of antiphlogistic Chunwang capsule |
| 05/27/2009 | CN100490849C Method for preparing houttuynia freeze-dried powder injection |
| 05/27/2009 | CN100490811C Piperazine derivative used as CCRS antagonist |
| 05/27/2009 | CN100490809C Tablet comprising cetirizine and pseudoephedrine |
| 05/27/2009 | CN100490804C Ophthalmological use of roflumilast for the treatment of diseases of the eye |
| 05/26/2009 | US7538215 Compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 05/26/2009 | US7538127 phenethanolamine derivatives like 1-(4-amino-3,5-dichlorophenyl)-2-[(6-{2-[(2,6-dichlorobenzyl)oxy]ethoxy}hexyl)amino]ethanol; respiratory diseases like bronchial asthma; selective stimulant of beta 2-adrenoreceptors; reductive amination; alkylation |
| 05/26/2009 | US7538121 Vanilloid receptor modulators |
| 05/26/2009 | US7538118 6-aminomorphinane derivatives, method for production and use thereof |
| 05/26/2009 | US7538091 D-retro-inverso amino acid sequence transporter peptide conjugated to nucleic acid biological effector; translocation across the membrane of pancreatic B-cells |
| 05/26/2009 | US7538089 Anti-inflammatory compounds and uses thereof |
| 05/26/2009 | US7537887 Relates to regulation of activity of NET (ERP/SAP-2) protein and to compounds which modify or regulate NET protein activity; methods of screening for agonists or antagonists of NET in order to identify new pro- or anti-angiogenic compounds |
| 05/26/2009 | CA2497857C Novel p-selectin ligand protein |
| 05/26/2009 | CA2474373C N-biphenylmethyl aminocycloalkanecarboxamide derivatives with a substituent on the methyl useful as bradykinin antagonists |
| 05/26/2009 | CA2464223C Quarternary ammonium compounds and their use as antimuscarinic agents |
| 05/26/2009 | CA2459432C Arylsulfonamide derivatives for use as ccr3 antagonists in the treatment of inflammatory and immunological disorders |
| 05/26/2009 | CA2436537C Pharmaceutical compositions comprising tiotropium salts and antihistamines |
| 05/26/2009 | CA2367017C Inhibitors of impdh enzyme |
| 05/26/2009 | CA2342211C Antibiotic compositions for treatment of the eye, ear and nose |
| 05/26/2009 | CA2254420C Substituted imidazolidine derivatives, their preparation, their use and pharmaceutical preparations comprising them |
| 05/26/2009 | CA2225903C Aromatic diselenides and selenosulfides, their preparation and their uses, more particularly their therapeutical use |
| 05/26/2009 | CA2216653C 1,3-dihydro-1-(phenylalkyl)-2h-imidazol-2-one derivatives having pdeiv and cytokine activity |
| 05/22/2009 | WO2009064959A1 Isoquinoline modulators of atp-binding cassette transporters |
| 05/22/2009 | WO2009064399A1 Monoclonal antibodies that bind to hgm-csf and medical compositions comprising same |
| 05/22/2009 | WO2009063993A1 Fused pyridine derivative and use thereof |
| 05/22/2009 | WO2009063990A1 Benzazepinone compound |
| 05/22/2009 | WO2009063226A2 Methods relating to breathing disorders |
| 05/22/2009 | WO2009063215A2 Use of crth2 antagonist compounds |
| 05/22/2009 | WO2009063202A2 Use of crth2 antagonist compounds |
| 05/22/2009 | WO2009062402A1 Quinazolinone derivatives, the preparation methods and uses thereof |
| 05/22/2009 | WO2009062258A1 N-containing heterocyclic compounds |
| 05/22/2009 | WO2009043507A3 Use of a peptide as a therapeutic agent |
| 05/22/2009 | WO2009043468A3 Use of corticotropin-releasing factor as a therapeutic agent |
| 05/22/2009 | WO2009040087A3 Therapeutic use of peptide yglf and combination with kvlpvpq |
| 05/22/2009 | WO2009040073A3 Use of a peptide as a therapeutic agent |
| 05/22/2009 | WO2009040032A3 Use of a peptide as a therapeutic agent |
| 05/22/2009 | WO2009040025A3 Use of neuropeptide sf, alone or in combination with glp-2, as a therapeutic agent |
| 05/22/2009 | WO2009039969A3 Use of a vla-4 inhibitor tetrapeptide, alone or in combination with bpp-b, as a therapeutic agent |
| 05/22/2009 | WO2009033822A3 Use of a combination of a cathepsin g fragment and teprotide as a therapeutic agent |
| 05/22/2009 | WO2009033812A3 Use of a combination of neuropeptide-ff and alpha-msh as a therapeutic agent |
| 05/22/2009 | WO2009033800A3 Use of a peptide as a therapeutic agent |
| 05/22/2009 | WO2009033771A3 Use of a peptide as a therapeutic agent |